Labor, Eva P.

HRN: 21-66-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2026
CEFTRIAXONE 1G (VIAL)
03/14/2026
03/21/2026
IV
2g
OD
TBI And Lacerated Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueCentral Nervous System    Compliance to guidelines: